The Agar Precipitation Technique and Its Application as a Diagnostic and
Analytical Method by F. PeetoomNomenclature is not discussed critically, and the style is diffuse and difficult to read. A translation which makes no better attempt at English style than "After the eleven each lasting one minute incubations the serum hardly contained …", etc. (p. 88), the strange punctuation, and the various misprints should not have appeared from a British publishing house.
From Nature 21 March 1964
100 Years Ago ' An Elizabethan Cookery-book' A Proper Newe Booke of Cokerye edited by Catherine F. FrereThe original Cambridge edition is dateless … the book was often reprinted before 1546, and was … the "Book of Cookery" of 1500 … As we turn over the leaves of the "Proper Newe Booke, " with its quaint recipes, couched in the "corrupted phonetic" of the golden age of English prose, we gather…"a little rushlight illumination on the culinary mysteries of the once busy kitchens, roofless and empty to-day, and on the hospitalities, feasting, and revels of the now silent dining halls of long ago. "
ALSO:
Prof. Arthur Keith's discourse on an anthropological study of some portraits of Shakespeare … is printed in … the British Medical Journal … Examination of the head of Shakespeare proves him to be a representative example of the shortheaded type, not of the early British breed, but of the round-headed race which entered Britain in the Bronze period about 2000 b.c. His brain capacity was more than 1900 cm., as compared with 1477 in an average Englishman. From Nature 19 March 1914 more efficiently degraded than whole apoptotic cells within the phagocyte, or maybe they are targeted or degraded differently. Apoptotic bodies may also be important in controlling immune responses to apoptotic cells 5 . It is possible that apoptotic bodies retain biological functions and act at sites well away from the dying cell. Given that apoptosis can drive cell regeneration in tissues 6 -an attractive replacement of the old with the new -it is particularly tempting to suggest that apoptotic-cell-derived bodies transport active components that contribute to these regenerative processes. Small vesicles have been found by others to export bioactive cargoes from nonapoptotic cells in response to various stimuli 7 . Although such vesicles are generally smaller than apoptotic bodies, the two types have certain structural characteristics in common. Exactly how PANX1 channels contribute to the functional (including possible pathological) attributes of apoptotic bodies, and perhaps other extracellular vesicles, will be valuable avenues of future investigation.
Poon and colleagues' work raises an issue of relevance to improved antibiotic design. Trova floxacin, a highly effective, broadspectrum fluoroquinolone antibiotic, was withdrawn because of adverse side effects in humans 8 . Fluoroquinolones in general represent some of the most commonly prescribed antibiotics, but they carry the risk of severe side effects that can harm multiple organ systems 9 . Could abrogating unwanted targeting of PANX1 channels by these drugs offer an opportunity to develop improved antibiotics? As yet, we do not know whether dysregulated production of apoptotic bodies has pathological consequences, or whether another, unidentified mechanism could cause adverse clinical effects when patients are treated with trovafloxacin -a mechanism that might be dependent or independent of PANX1-channel inhibition. What is crucial to determine is the functional diversity of PANX1 channels, and the pathological consequences of their blockade.
As always, the unexpected is the most fascinating. There is no doubt that this work will stimulate researchers in the seemingly disparate areas of apoptosis and antibiotics to find out more about PANX1. 
BONE BIOLOGY

Vessels of rejuvenation
The identification of specialized endothelial-cell populations in the blood vessels of bones, and their signalling pathways, reveals how the vasculature contributes to bone formation. See Article p.323 & Letter p.376
he different structural and metabolic requirements of organs and tissues prompt the formation of specialized blood vessels during development 1 , which deliver molecules that instruct tissues on their fates 2, 3 . This process requires crosstalk between organs and the vasculature: organs generate local growth factors that attract blood vessels toward metabolically active regions, and the vessels release molecules (known as angio crine signals) that affect cell differentiation in the developing organs. It is becoming increasingly clear that these interactions are influenced by the endothelial cells that line the inner surface of blood vessels. In two papers 4, 5 in this issue, Adams and colleagues demonstrate that the bone vasculature contains specialized endothelial cells with signalling properties that support bone maturation and regeneration. As well as providing insight into the tissue specificity of angiocrine signalling, the findings have direct clinical relevance.
In the first paper, Kusumbe et al. 4 (page 323) began by mapping gene expression, metabolic activity and cell-surface markers in the developing postnatal bone vasculature of mice. The authors distinguished two new subpopulations of endothelial cell (EC) that they term type H and type L ECs. Interestingly, they found that osteoprogenitor cells, which differentiate into bone-forming osteoblasts, preferentially associate with type H ECs because these cells are a rich source of several growth factors relevant for the survival and proliferation of osteoprogenitors (Fig. 1) . With age, however, both the type H EC and the osteoprogenitor populations decline. The authors also report that type H and type L ECs express different levels of the α-subunit of hypoxia-inducible factor-1 (Hif-1α), a transcription factor that plays a central part in regulating cell metabolism and forming new blood vessels (angiogenesis) 6 . To assess the functional relevance of this protein in the endothelium, the authors genetically manipulated Hif-1α levels, and found that loss of the protein strongly reduced the number of type H ECs and osteoprogenitors, without affecting type L ECs. Conversely, enhanced Hif-1α expression increased the number of type H ECs, particularly in the metaphysis region of long bones, and this was accompanied by a significant increase in osteoprogenitor numbers and bone formation.
The observation that proliferation of type H ECs and osteoprogenitor formation positively correlates with endothelial Hif-1α levels raised the idea that Hif-1α augmentation might induce angiogenesis and osteogenesis in aged animals, in which bone formation is impaired. To test this, the authors 4 treated aged mice with deferoxamine mesylate (DFM), a chemical that inhibits Hif-1α degradation by targeting PHD enzymes, and observed a substantial expansion of type H ECs, osteoprogenitors and osteoblasts, and an increase in bone mass. These findings suggest that inducing type H ECs is key to maintaining bone remodelling during ageing.
Ramasamy et al. 5 (page 376) further investigated the crosstalk between the endothelium and osteogenesis by studying the endothelial Dll4-Notch signalling pathway, which has previously been defined as a negative regulator of angiogenesis in many organs 7 . Surprisingly, the authors found that Dll4-Notch signals positively regulate angiogenesis in postnatal long bones -highlighting the unusual properties of bone endothelium. Loss of endothelial Notch signalling in mice was associated with reduced bone mass and shortening of long bones and, conversely, activating these signals augmented osteogenesis and bone size. In line with type H ECs playing a key part in bone blood-vessel growth and osteogenesis, this cell population increased on activation of endothelial Notch.
The authors 5 next analysed factors secreted by ECs in mice that were genetically engineered to have active Notch signalling, and found a strong upregulation of Noggin, an antagonist of growth factors collectively known as bone-morphogenetic proteins. Administering Noggin to Notch-deficient mice restored angiogenesis and bone formation, and the molecular mechanism underlying this rescue was traced to effects of Noggin on restoring both local expression of the protein Sox9, which is relevant for initiating the carti lage-bone transition, and levels of vascular endothelial growth factor. Thus, Notch and the angiocrine release of Noggin link the type H endothelium to osteogenesis.
These findings generate several questions. For example, how can Notch signalling switch between negative 7 and positive regulation of angiogenesis in a tissue-specific manner? Ramasamy and co-workers suggest that this may involve Hes5, a transcription-regulating protein that acts downstream of Notch, but other environmental and tissue-specific cues may be involved. The demonstration that Hif-1α is crucial in maintaining the type H EC population, but that these cells are lost in aged animals, suggests that loss of Hif-1α signalling may be involved in age-related bone In addition to prompting these biological questions, Adams and colleagues' work 4,5 has important clinical implications. Bone is continually deposited by osteoblasts, which are activated by bone fractures. But osteoblast activity declines with age, leading to bone loss and impaired fracture healing. This age-related osteoporosis is the most common cause of all bone diseases, and is associated with other health problems and deaths, especially in post-menopausal women. Osteoporosis is also a frequent complication in patients receiving long-term corticosteroid treatment following organ transplantation. The data provided by these and other 9 mouse studies suggest that DFM treatment might help to restore boneformation deficits. DFM is registered for clinical use, currently for the treatment of ironoverloaded patients and in combination with dialysis, so clinical trials to examine the drug in the context of osteoporosis are foreseeable. DFM might also be considered as a combined therapy with bisphosphonate drugs 10 , which are used to slow the loss of bone.
Excessive bone loss can also result from the reduced gravitational forces experienced during long periods of space travel. Coincidentally 
